GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. Drugs (Pharmaceuticals), Suits and Litigation (Civil), Liability for Products, Compensation for Damages (Law), Heartburn, GSK PLC GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. NYT > Business
Headlines